Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MMSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.680B
March 31, 2026 1.627B
December 31, 2025 1.584B
September 30, 2025 1.529B
June 30, 2025 1.488B
March 31, 2025 1.428B
December 31, 2024 1.379B
September 30, 2024 1.323B
June 30, 2024 1.282B
March 31, 2024 1.240B
December 31, 2023 1.202B
September 30, 2023 1.230B
June 30, 2023 1.204B
March 31, 2023 1.172B
December 31, 2022 1.144B
September 30, 2022 1.089B
June 30, 2022 1.073B
March 31, 2022 1.057B
December 31, 2021 1.040B
September 30, 2021 1.013B
June 30, 2021 992.43M
March 31, 2021 976.69M
December 31, 2020 958.58M
September 30, 2020 933.84M
June 30, 2020 928.85M
Date Value
March 31, 2020 939.80M
December 31, 2019 949.94M
September 30, 2019 949.24M
June 30, 2019 950.68M
March 31, 2019 940.11M
December 31, 2018 932.78M
September 30, 2018 923.21M
June 30, 2018 699.25M
March 31, 2018 688.51M
December 31, 2017 676.33M
September 30, 2017 666.82M
June 30, 2017 666.48M
March 31, 2017 652.34M
December 31, 2016 498.19M
September 30, 2016 485.94M
June 30, 2016 479.99M
March 31, 2016 472.32M
December 31, 2015 466.10M
September 30, 2015 458.56M
June 30, 2015 452.80M
March 31, 2015 442.70M
December 31, 2014 435.26M
September 30, 2014 424.25M
June 30, 2014 415.90M
March 31, 2014 409.63M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. 6.206B
DexCom, Inc. 2.621B
Globus Medical, Inc. 4.769B
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M

Shareholders Equity (Quarterly) Related Metrics